Pure Financial Advisors LLC Has $786,000 Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pure Financial Advisors LLC increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.8% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,505 shares of the medical equipment provider’s stock after acquiring an additional 26 shares during the period. Pure Financial Advisors LLC’s holdings in Intuitive Surgical were worth $786,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ISRG. Godsey & Gibb Inc. grew its stake in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical in the fourth quarter valued at $36,000. Capital Performance Advisors LLP acquired a new position in Intuitive Surgical during the third quarter worth $38,000. Finally, DT Investment Partners LLC lifted its holdings in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after acquiring an additional 36 shares during the period. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Up 1.9 %

NASDAQ:ISRG opened at $604.12 on Wednesday. The stock’s fifty day simple moving average is $541.80 and its 200-day simple moving average is $500.76. The firm has a market capitalization of $215.18 billion, a P/E ratio of 97.13, a P/E/G ratio of 5.04 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $362.14 and a 12-month high of $606.27.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the completion of the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 43,509 shares of company stock worth $22,602,212. Insiders own 0.80% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent analyst reports. Piper Sandler reiterated an “overweight” rating and set a $538.00 target price (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Citigroup lifted their target price on shares of Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. JPMorgan Chase & Co. increased their price target on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Leerink Partners increased their target price on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.